Ahmed Nadeem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmed Nadeem has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Clifton G. Fulmer
Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA
2 shared publications - Fatima Zehra Shah
Cleveland Clinic Foundation, Cleveland, OH
2 shared publications - Abhishek Kataria
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA
1 shared publication - Adeel Anwaar
Pakistan Kidney and Liver Institute and Research Center, Lahore, Pakistan
1 shared publication - Aidan David
College of Arts and Sciences, Case Western Reserve University, Cleveland, OH
1 shared publication - Ari Garber
Cleveland Clinic Diagnostics Institute, Cleveland, OH
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
Esophageal Squamous Papillomas: Human Papillomavirus Association and Natural History
Introduction: Esophageal squamous papillomas (ESPs) are rare epithelial lesions with an incompletely understood pathogenesis and uncertain malignant potential. Prior studies evaluating the association between ESP and human papillomavirus (HPV) have demonstrated conflicting results, often limited by small cohorts and heterogeneous HPV detection methodologies. Methods: We conducted a retrospective cohort study of histologically confirmed ESPs at Cleveland Clinic between January 2019 and July 2023. Clinical, endoscopic, and histopathologic data were collected. Formalin-fixed, paraffin-embedded tissue underwent RNA in situ hybridization (RNA ISH) targeting E6/E7 mRNA to detect transcriptionally active low- and high-risk HPV subtypes. Results: 184 ESP cases were identified, representing the largest single-center cohort. Lesions were predominantly solitary, small (<5 mm), and located in the mid-esophagus. GERD and dysphagia were the most common indications for endoscopy. No lesion demonstrated dysplasia, epidermoid metaplasia, or invasive carcinoma at index endoscopy. All evaluable lesions were negative for transcriptionally active HPV by RNA ISH (0/177; 95% CI, 0–2.1%). Follow-up endoscopy was available in 70 patients (38%), with a median follow-up of 24 months and surveillance extending to ≥4 years. No dysplasia / malignant transformation was observed during available follow-up. Persistent/residual ESP was identified in 6 patients following non-removal or biopsy-only sampling of the index lesion. Conclusions: The absence of transcriptionally active HPV supports a limited role for HPV in ESP pathogenesis and does not support routine HPV testing in typical, non-dysplastic ESPs. Our findings support the generally benign natural history of ESPs and highlight the need for prospective studies with standardized long-term surveillance to better define their malignant potential
- 12 November 2026
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
Open AccessEsophageal Squamous Papillomas: Human Papillomavirus Association and Natural History
Introduction: Esophageal squamous papillomas (ESPs) are rare epithelial lesions with an incompletely understood pathogenesis and uncertain malignant potential. Prior studies evaluating the association between ESP and human papillomavirus (HPV) have demonstrated conflicting results, often limited by small cohorts and heterogeneous HPV detection methodologies. Methods: We conducted a retrospective cohort study of histologically confirmed ESPs at Cleveland Clinic between January 2019 and July 2023. Clinical, endoscopic, and histopathologic data were collected. Formalin-fixed, paraffin-embedded tissue underwent RNA in situ hybridization (RNA ISH) targeting E6/E7 mRNA to detect transcriptionally active low- and high-risk HPV subtypes. Results: 184 ESP cases were identified, representing the largest single-center cohort. Lesions were predominantly solitary, small (<5 mm), and located in the mid-esophagus. GERD and dysphagia were the most common indications for endoscopy. No lesion demonstrated dysplasia, epidermoid metaplasia, or invasive carcinoma at index endoscopy. All evaluable lesions were negative for transcriptionally active HPV by RNA ISH (0/177; 95% CI, 0–2.1%). Follow-up endoscopy was available in 70 patients (38%), with a median follow-up of 24 months and surveillance extending to ≥4 years. No dysplasia / malignant transformation was observed during available follow-up. Persistent/residual ESP was identified in 6 patients following non-removal or biopsy-only sampling of the index lesion. Conclusions: The absence of transcriptionally active HPV supports a limited role for HPV in ESP pathogenesis and does not support routine HPV testing in typical, non-dysplastic ESPs. Our findings support the generally benign natural history of ESPs and highlight the need for prospective studies with standardized long-term surveillance to better define their malignant potential
- Open Access
- 15 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7705-7708
A rare anatomical variant: triple vas deferens encountered during varicocelectomy – a case report
Introduction and importance: The anatomical variations in the vas deferens are incidentally found during inguinoscrotal surgeries. These variations include agenesis, bifurcation, duplication, or triplication of the vas deferens due to embryological alteration. There have been many cases of duplication of the vas deferens and bifurcation of the vas deferens with polyorchidism reported in the literature. However, triplication of the vas deferens remains an extremely rare clinical entity, and only one case has been reported in the literature before this study. Case presentation: A 29-year-old male with primary infertility was diagnosed with grade 4 varicoceles after clinical and radiological evaluation. He underwent bilateral microsurgical varicocelectomy. Intraoperatively, a rare triple vas deferens was found incidentally on the left. Recovery was smooth, and semen parameters improved significantly after 1 year. Clinical discussion: Triple vas deferens is an extremely rare anomaly with only one prior case reported. Often diagnosed incidentally during surgery, preoperative detection remains challenging. Our case adds to the limited literature, emphasizing the need for awareness, improved diagnostic tools, and a registry to better understand and classify this condition. Conclusion: Urologists should keep in mind the possibility of such variations during inguinoscrotal surgeries to avoid iatrogenic injury. Infertility patients should be evaluated for the possibility of encountering such abnormal variations during surgical management.
- 15 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7705-7708
Open AccessA rare anatomical variant: triple vas deferens encountered during varicocelectomy – a case report
Introduction and importance: The anatomical variations in the vas deferens are incidentally found during inguinoscrotal surgeries. These variations include agenesis, bifurcation, duplication, or triplication of the vas deferens due to embryological alteration. There have been many cases of duplication of the vas deferens and bifurcation of the vas deferens with polyorchidism reported in the literature. However, triplication of the vas deferens remains an extremely rare clinical entity, and only one case has been reported in the literature before this study. Case presentation: A 29-year-old male with primary infertility was diagnosed with grade 4 varicoceles after clinical and radiological evaluation. He underwent bilateral microsurgical varicocelectomy. Intraoperatively, a rare triple vas deferens was found incidentally on the left. Recovery was smooth, and semen parameters improved significantly after 1 year. Clinical discussion: Triple vas deferens is an extremely rare anomaly with only one prior case reported. Often diagnosed incidentally during surgery, preoperative detection remains challenging. Our case adds to the limited literature, emphasizing the need for awareness, improved diagnostic tools, and a registry to better understand and classify this condition. Conclusion: Urologists should keep in mind the possibility of such variations during inguinoscrotal surgeries to avoid iatrogenic injury. Infertility patients should be evaluated for the possibility of encountering such abnormal variations during surgical management.
- 30 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (6) , e266424
AA amyloidosis with multiorgan involvement secondary to familial Mediterranean fever (FMF): dreadful consequences of delayed diagnosis and management
Familial Mediterranean fever (FMF) is an autoinflammatory disorder that can lead to progressive AA amyloidosis if not diagnosed and treated promptly. We present a case of a middle-aged male with extensive multiorgan involvement due to AA amyloidosis secondary to FMF. His medical journey spans over a decade, with disease progression affecting the kidneys, bone marrow, liver, heart, lungs and gastrointestinal tract. Genetic testing confirmed M694V and V726A mutations in the Mediterranean Fever gene (MEFV). This is the first reported case of FMF-associated AA amyloidosis with extensive multiorgan involvement, proven by biopsy, in a single individual. It highlights the diagnostic and therapeutic delays contributing to disease progression, posing significant management challenges, and emphasises the importance of high clinical suspicion, timely workup and early intervention.
- 30 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (6) , e266424
AA amyloidosis with multiorgan involvement secondary to familial Mediterranean fever (FMF): dreadful consequences of delayed diagnosis and management
Familial Mediterranean fever (FMF) is an autoinflammatory disorder that can lead to progressive AA amyloidosis if not diagnosed and treated promptly. We present a case of a middle-aged male with extensive multiorgan involvement due to AA amyloidosis secondary to FMF. His medical journey spans over a decade, with disease progression affecting the kidneys, bone marrow, liver, heart, lungs and gastrointestinal tract. Genetic testing confirmed M694V and V726A mutations in the Mediterranean Fever gene (MEFV). This is the first reported case of FMF-associated AA amyloidosis with extensive multiorgan involvement, proven by biopsy, in a single individual. It highlights the diagnostic and therapeutic delays contributing to disease progression, posing significant management challenges, and emphasises the importance of high clinical suspicion, timely workup and early intervention.
- Open Access
- 20 December 2024
- Published by Oxford University Press (OUP) in Crohn's & Colitis 360
- Vol. 7 (1) , otae066
Early Onset Active Inflammatory Bowel Disease Is Associated With Psychiatric Comorbidities: A Multi-Network Propensity-Matched Cohort Study
Background: Psychiatric disease burden in patients with Inflammatory bowel disease (IBD) has risen substantially over the past few decades. However, there is limited data on the relationship between IBD disease activity and the incidence of psychiatric comorbidities. We sought to conduct a population-based study to investigate the impact of early onset disease activity in newly diagnosed IBD patients on psychiatric disease diagnoses and medication usage. Methods: We performed a retrospective cohort study using the TriNetX database. We identified all adult patients diagnosed with IBD and documented IBD-specific medication use. We stratified these IBD patients into 2 cohorts based on IBD Disease Activity, occurring 6 months to 1 year after initial IBD diagnosis. Active IBD was defined as the utilization of steroids and/or elevated fecal calprotectin [≥200 µg/g] occurring 6 months to 1 year after initial IBD diagnosis. We examined the outcomes of psychiatric disease diagnoses and psychotropic medication prescriptions occurring 1 year after the initial diagnosis. Results: Out of 69 105 patients with an IBD diagnosis during the study period, after propensity score matching, 16 922 IBD patients each were included in the 2 cohorts based on disease activity. Patients with active IBD had significantly higher odds of developing major depressive disorder, anxiety disorder, bipolar disorder, alcohol use disorder, opiate use disorder, attention deficit hyperactivity disorder, and obsessive-compulsive disorder. Additionally, patients with active IBD also had significantly higher odds of using all studied psychotropic medications, including antidepressants, antipsychotic medications, anxiolytics, sedatives, hypnotic medications, mood stabilizers, stimulant medications, and medications used for substance use disorders (including alcohol, opioid, and tobacco use). Conclusions: Active IBD shortly after the IBD diagnosis is associated with a higher incidence of psychiatric comorbidities. Awareness of behavioral health in IBD is important, and proper treatment is necessary.
- 20 December 2024
- Published by Oxford University Press (OUP) in Crohn's & Colitis 360
- Vol. 7 (1) , otae066
Open AccessEarly Onset Active Inflammatory Bowel Disease Is Associated With Psychiatric Comorbidities: A Multi-Network Propensity-Matched Cohort Study
Background: Psychiatric disease burden in patients with Inflammatory bowel disease (IBD) has risen substantially over the past few decades. However, there is limited data on the relationship between IBD disease activity and the incidence of psychiatric comorbidities. We sought to conduct a population-based study to investigate the impact of early onset disease activity in newly diagnosed IBD patients on psychiatric disease diagnoses and medication usage. Methods: We performed a retrospective cohort study using the TriNetX database. We identified all adult patients diagnosed with IBD and documented IBD-specific medication use. We stratified these IBD patients into 2 cohorts based on IBD Disease Activity, occurring 6 months to 1 year after initial IBD diagnosis. Active IBD was defined as the utilization of steroids and/or elevated fecal calprotectin [≥200 µg/g] occurring 6 months to 1 year after initial IBD diagnosis. We examined the outcomes of psychiatric disease diagnoses and psychotropic medication prescriptions occurring 1 year after the initial diagnosis. Results: Out of 69 105 patients with an IBD diagnosis during the study period, after propensity score matching, 16 922 IBD patients each were included in the 2 cohorts based on disease activity. Patients with active IBD had significantly higher odds of developing major depressive disorder, anxiety disorder, bipolar disorder, alcohol use disorder, opiate use disorder, attention deficit hyperactivity disorder, and obsessive-compulsive disorder. Additionally, patients with active IBD also had significantly higher odds of using all studied psychotropic medications, including antidepressants, antipsychotic medications, anxiolytics, sedatives, hypnotic medications, mood stabilizers, stimulant medications, and medications used for substance use disorders (including alcohol, opioid, and tobacco use). Conclusions: Active IBD shortly after the IBD diagnosis is associated with a higher incidence of psychiatric comorbidities. Awareness of behavioral health in IBD is important, and proper treatment is necessary.
- Open Access
- 27 June 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (7) , e01409
Lymphocytic Colitis With Enterocolic Lymphocytic Phlebitis
Enterocolic lymphocytic phlebitis is a rare lymphocytic vasculitis afflicting the gastrointestinal veins without involving the arterial system. Lymphocytic colitis is a more common pathology described as lymphocytic inflammation of the colonic epithelium. Concurrence of both these pathologies is extremely rare. We describe a 53-year-old man presenting with chronic watery diarrhea, abdominal pain, and weight loss. Colonoscopic examination revealed normal-appearing mucosa, but biopsy findings revealed lymphocytic colitis with coexisting enterocolic lymphocytic phlebitis. The patient was started on oral budesonide and responded to the treatment with symptomatic and histopathological resolution.
- 27 June 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (7) , e01409
Open AccessLymphocytic Colitis With Enterocolic Lymphocytic Phlebitis
Enterocolic lymphocytic phlebitis is a rare lymphocytic vasculitis afflicting the gastrointestinal veins without involving the arterial system. Lymphocytic colitis is a more common pathology described as lymphocytic inflammation of the colonic epithelium. Concurrence of both these pathologies is extremely rare. We describe a 53-year-old man presenting with chronic watery diarrhea, abdominal pain, and weight loss. Colonoscopic examination revealed normal-appearing mucosa, but biopsy findings revealed lymphocytic colitis with coexisting enterocolic lymphocytic phlebitis. The patient was started on oral budesonide and responded to the treatment with symptomatic and histopathological resolution.
- Open Access
- 29 February 2024
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 26 (5) , 125-136
Peri-Operative Optimization of Patients with Crohn’s Disease
Purpose of Review: The management of patients with Crohn’s disease (CD) undergoing surgery is complex and optimization of modifiable factors perioperatively can improve outcomes. This review focuses on the perioperative management of CD patients undergoing surgery, emphasizing the need for a multi-disciplinary approach. Recent Findings: Research highlights the benefits of a comprehensive strategy, involving nutritional optimization, psychological assessment, and addressing septic complications before surgery. Despite many CD patients being on immune-suppressing medications, studies indicate that most of these medications are safe to use and should not delay surgery. However, a personalized approach for each case is needed. Summary: This review underscores the importance of multi-disciplinary team led peri-operative management of CD patients. We suggest that this can be done at a dedicated perioperative clinic for prehabilitation, with the potential to enhance outcomes for CD patients undergoing surgery.
- 29 February 2024
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 26 (5) , 125-136
Open AccessPeri-Operative Optimization of Patients with Crohn’s Disease
Purpose of Review: The management of patients with Crohn’s disease (CD) undergoing surgery is complex and optimization of modifiable factors perioperatively can improve outcomes. This review focuses on the perioperative management of CD patients undergoing surgery, emphasizing the need for a multi-disciplinary approach. Recent Findings: Research highlights the benefits of a comprehensive strategy, involving nutritional optimization, psychological assessment, and addressing septic complications before surgery. Despite many CD patients being on immune-suppressing medications, studies indicate that most of these medications are safe to use and should not delay surgery. However, a personalized approach for each case is needed. Summary: This review underscores the importance of multi-disciplinary team led peri-operative management of CD patients. We suggest that this can be done at a dedicated perioperative clinic for prehabilitation, with the potential to enhance outcomes for CD patients undergoing surgery.